STEEPLE bleeding criteria
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation [1]
- Major bleeding
Fatal bleeding Retroperitoneal, intracranial, or intraocular bleeding Bleeding that causes hemodynamic compromise requiring specific treatment Bleeding that requires intervention (surgical or endoscopic) or decompression of a closed space to stop or control the event Clinically overt bleeding, requiring any transfusion of ≥1 U PRBC or whole blood Clinically overt bleeding, causing a decrease in hemoglobin of ≥3 g/dL (or, if hemoglobin level is not available, a decrease in hematocrit of ≥10%)
- Minor
Gross hematuria not associated with trauma (eg, from instrumentation) Epistaxis that is prolonged, is repeated, or requires plugging or intervention Gastrointestinal hemorrhage Hemoptysis Subconjunctival hemorrhage Hematoma >5 cm or leading to prolonged or new hospitalization Clinically overt bleeding, causing a decrease in hemoglobin of 2 to 3 g/dL Uncontrolled bleeding requiring protamine sulfate administration Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation}}
References
- ↑ Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J; et al. (2009). "Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial". Circulation. 119 (5): 680–6. doi:10.1161/CIRCULATIONAHA.108.803528. PMID 19171853.
See also
- Aneurysm
- Coagulation
- Upper gastrointestinal bleed
- Vaginal bleeding
- Intracerebral hemorrhage - bleeding in the brain caused by the rupture of a blood vessel within the head. See also hemorrhagic stroke.
- Subarachnoid hemorrhage (SAH) implies the presence of blood within the subarachnoid space from some pathologic process. The common medical use of the term SAH refers to the nontraumatic types of hemorrhages, usually from rupture of a berry aneurysm or arteriovenous malformation(AVM). The scope of this article is limited to these nontraumatic hemorrhages.
- Intracranial hemorrhage
- Cerebral hemorrhage
- Postpartum hemorrhage
- Hematuria - blood in the urine from urinary bleeding
- Hemoptysis - coughing up blood from the lungs
- Hematemesis - vomiting fresh blood
- Hematochezia - rectal blood
- Exsanguination - death by bleeding
bg:Кръвоизлив bs:Krvarenje ca:Hemorràgia cs:Krvácení de:Blutung eu:Odoljario it:Emorragia he:דימום la:Haemorrhagia lt:Kraujavimas nl:Versterkte bloedingsneiging qu:Yawar apariy sv:Blödning